Skp2在恶性肿瘤的发生及治疗中的研究进展

被引:5
作者
孙雅静
机构
[1] 天津市第五中心医院病理科
关键词
细胞S期激酶相关蛋白2; 细胞周期; 肿瘤; 治疗;
D O I
暂无
中图分类号
R730.2 [肿瘤病理学、病因学];
学科分类号
100214 [肿瘤学];
摘要
肿瘤发生的根本原因是细胞周期调控紊乱, 细胞S期激酶相关蛋白2(S-phase associated kinase protein 2, Skp2)是新近认识的细胞周期调控的蛋白之一。在多种肿瘤中高表达, 例如:直肠癌, 肺癌, 胶质瘤, 前列腺癌等;并影响患者预后。Skp2作为肿瘤基因治疗的新的靶点, 抑制其表达能有效的控制肿瘤的发展, 提高患者的预后, 现就Skp2的结构、功能和与肿瘤的相关性进行综述。
引用
收藏
相关论文
共 32 条
[1]
Paeoniflorin exerts antitumor effects by inactivating S phase kinase-associated protein 2 in glioma cells [J].
Ouyang, Jia ;
Xu, Hui ;
Li, Ming ;
Dai, Xingliang ;
Fu, Fengqing ;
Zhang, Xueguang ;
Lan, Qing .
ONCOLOGY REPORTS, 2018, 39 (03) :1052-1062
[2]
Downregulation of SKP2 in Papillary Thyroid Cancer Acts Synergistically With TRAIL on Inducing Apoptosis via ROS [J].
Pratheeshkumar, Poyil ;
Siraj, Abdul K. ;
Divya, Sasidharan Padmaja ;
Parvathareddy, Sandeep Kumar ;
Begum, Rafia ;
Melosantos, Roxanne ;
Al-Sobhi, Saif S. ;
Al-Dawish, Mohammed ;
Al-Dayel, Fouad ;
Al-Kuraya, Khawla S. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (04) :1530-1544
[3]
Cell cycle-dependent regulation of cytoglobin by Skp2 [J].
John, Rince ;
Atri, Yama ;
Chand, Vaibhav ;
Jaiswal, Neha ;
Raj, Kritika ;
Nag, Alo .
FEBS LETTERS, 2017, 591 (21) :3507-3522
[4]
C-terminal binding protein-2 promotes cell proliferation and migration in breast cancer via suppression of p16INK4A [J].
Yang, Xiaojing ;
Sun, Yi ;
Li, Hongling ;
Shao, Yuhui ;
Zhao, Depeng ;
Yu, Weiwei ;
Fu, Jie .
ONCOTARGET, 2017, 8 (16) :26154-26168
[5]
Matrine derivative YF-18 inhibits lung cancer cell proliferation and migration through down-regulating Skp2 [J].
Wu, Lichuan ;
Wang, Guizhen ;
Wei, Jinrui ;
Huang, Na ;
Zhang, Sen ;
Yang, Fangfang ;
Li, Ming ;
Zhou, Guangbiao ;
Wang, Lisheng .
ONCOTARGET, 2017, 8 (07) :11729-11738
[6]
The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor [J].
Xu, Jie ;
Zhou, Weihua ;
Yang, Fei ;
Chen, Guoan ;
Li, Haomin ;
Zhao, Yongchao ;
Liu, Pengyuan ;
Li, Hua ;
Tan, Mingjia ;
Xiong, Xiufang ;
Sun, Yi .
NATURE COMMUNICATIONS, 2017, 8
[7]
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer.[J].Signoretti Sabina;Di Marcotullio Lucia;Richardson Andrea;Ramaswamy Sridhar;Isaac Beth;Rue Montserrat;Monti Franco;Loda Massimo;Pagano Michele.The Journal of clinical investigation.2016, 11
[8]
Skp1: Implications in cancer and SCF-oriented anti-cancer drug discovery.[J].Muzammal Hussain;Yongzhi Lu;Yong-Qiang Liu;Kai Su;Jiancun Zhang;Jinsong Liu;Guang-Biao Zhou.Pharmacological Research.2016,
[9]
Skp2 Regulates the Expression of MMP-2 and MMP-9, and Enhances the Invasion Potential of Oral Squamous Cell Carcinoma [J].
Yamada, Shin-ichi ;
Yanamoto, Souichi ;
Naruse, Tomofumi ;
Matsushita, Yuki ;
Takahashi, Hidenori ;
Umeda, Masahiro ;
Nemoto, Takayuki K. ;
Kurita, Hiroshi .
PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (03) :625-632
[10]
Skp2 is associated with paclitaxel resistance in prostate cancer cells [J].
Yang, Yeguo ;
Lu, Yi ;
Wang, Lihui ;
Mizokami, Atsushi ;
Keller, Evan T. ;
Zhang, Jian ;
Fu, Jiejun .
ONCOLOGY REPORTS, 2016, 36 (01) :559-566